Company Filing History:
2 out of 88 
2 out of 576 
Years Active: 2019-2020
Title: Lars Pache: Innovator in HIV Therapy
Introduction
Lars Pache is a notable inventor based in La Jolla, California. He has made significant contributions to the field of HIV therapy through his innovative research and patents. With a total of 2 patents, Pache's work focuses on the modulation of apoptosis proteins to combat human immunodeficiency virus (HIV).
Latest Patents
Lars Pache's latest patents include the use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy. These patents describe methods for utilizing compounds that modulate the activity of IAPs, either alone or in combination with other therapeutic agents, to treat HIV. The patents emphasize the administration of a therapeutically effective amount of at least one IAP antagonist to individuals in need of HIV treatment.
Career Highlights
Throughout his career, Lars Pache has worked with esteemed institutions such as the Sanford Burnham Prebys Medical Discovery Institute and the Salk Institute for Biological Studies. His research has been pivotal in advancing therapeutic strategies for HIV, showcasing his dedication to improving patient outcomes.
Collaborations
Lars Pache has collaborated with notable colleagues, including Sumit K Chanda and Mitchell Dennis Vamos. These partnerships have further enriched his research and contributed to the development of innovative therapies.
Conclusion
Lars Pache's contributions to HIV therapy through his patents and research collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical science and offers hope for improved treatments for those affected by HIV.